Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(129 ratings | avg ★ 4.6)
App Store (129 ratings)
Total Downloads (Android)
100+
Last 28 days
Revenue
$898
AR
$10,776
MRR
$1,193
ARR
$14,316
Cash Flow Index
0.8x
Active Subscriptions
756
Active Trials
2
ARPAS
$1.18
Paid Subscriber Share (snapshot)
99.7%
Active Customers
636
New Customers
171
Subscription Penetration
118.9%
ARPU
$1.41
RPD
$1.41
ARPPU
$1.58
LTV
$16
MRR Growth (28d)
-2.2%
Subscriber Growth (28d)
-4.1%
All data is verified through RevenueCat. Last updated: Aug 12, 2026, 05:31:05 AM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$23,860
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗AbMaxx
FOR SALELast 30 days rev
$30,456
MRR
$9,876
DailyGlowUp
FOR SALELast 30 days rev
$26,733
MRR
$13,000
TrackAI
FOR SALELast 30 days rev
$24,523
MRR
$21,290

Brainrot.mov
FOR SALELast 30 days rev
$9,719
MRR
$11,279
PepKit
FOR SALELast 30 days rev
$7,680
MRR
$4,062

whatstheapp
Last 30 days rev
$8,424
MRR
$699



